Literature DB >> 21752585

Results of cemented femoral revisions for periprosthetic femoral fractures in the elderly.

Kristoff Corten1, Steven J Macdonald, Richard W McCalden, Robert B Bourne, Douglas D R Naudie.   

Abstract

The treatment goals of Vancouver type B2 periprosthetic femoral fractures in elderly patients with a limited life expectancy are early weight bearing without compromising the fracture healing. Thirty-one patients with a mean age of 82 years were treated with a long cemented stem with additional allograft or plate fixation, followed by immediate full weight bearing. Seven major complications occurred within the first 3 months postoperatively. Forty-three percent of patients had died within the first year with their implant in place. Sixteen patients had survived more than 1 year. None of the implants had to be revised at a mean follow-up of 46 months. The results of this series suggest that this technique can provide acceptable results and offers the advantages of reduced cost and early weight bearing. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752585     DOI: 10.1016/j.arth.2011.03.050

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  4 in total

1.  Treatment of Vancouver type B2 periprosthetic femoral fractures.

Authors:  Carl Haasper; Mohammad Ali Enayatollahi; Thorsten Gehrke
Journal:  Int Orthop       Date:  2015-08-20       Impact factor: 3.075

2.  Outcome of surgical treatment of 54 Periprosthetic femoral fractures after total hip arthroplasty at mid term follow-up.

Authors:  Ibrahim Akkawi; Daniele Fabbri; Matteo Romantini; Massimo Laus; Alfonso Calogero
Journal:  Acta Biomed       Date:  2021-11-03

3.  The Outcomes of Cemented Femoral Revisions for Periprosthetic Femoral Fractures in the Elderly: Comparison with Cementless Stems.

Authors:  Pavel Sponer; Martin Korbel; Michal Grinac; Libor Prokes; Ales Bezrouk; Tomas Kucera
Journal:  Clin Interv Aging       Date:  2021-10-27       Impact factor: 4.458

4.  Comparative Study on the Application of Mesenchymal Stromal Cells Combined with Tricalcium Phosphate Scaffold into Femoral Bone Defects.

Authors:  Pavel Šponer; Tomáš Kučera; Jindra Brtková; Karel Urban; Zuzana Kočí; Pavel Měřička; Aleš Bezrouk; Šimona Konrádová; Alžběta Filipová; Stanislav Filip
Journal:  Cell Transplant       Date:  2018-09-11       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.